Cardio-optics Reports IR Blood Imaging Results
BOULDER, Colo., Oct. 3 -- Cardio-optics Inc. has completed a series of successful animal experiments of its patented Trans Blood Vision System. The experiments, conducted over a period of six weeks, verify that Cardio-optics' Trans Blood Vision technology, which uses infrared illumination, can see through flowing blood. This represents a major breakthrough for surgical procedures that require surgeons to work through blood, such as heart surgery and intravascular procedures.
"These experiments have confirmed the soundness of the technology and have established proof of concept in vivo," said Larry Blankenship, president and CEO of Cardio-optics. "We remain on track to have our first products ready for market late next year."
Cardio-optics medical director Bruce Ferguson said, "We have seen, for the first time, demonstration of the ability to see intracardiac structures in the presence of flowing blood in a live animal using infrared technology for visibility. He will present the results of these studies at the American Heart Association meeting in Anaheim, Calif., November.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024